aom
acut
otiti
media
hcv
human
coronaviru
hrv
human
rhinoviru
mee
middl
ear
effus
ome
otiti
media
effus
pb
phosphatebuff
salin
rsv
respiratori
syncyti
viru
rtpcr
reversetranscriptas
polymeras
chain
reaction
object
studi
associ
human
rhinoviru
hrv
respiratori
syncyti
viru
rsv
human
coronaviru
infect
children
age
month
year
otiti
media
effus
ome
determin
long
hrv
rna
detect
hrv
infect
method
middl
ear
effus
mee
sampl
collect
time
tympanostomi
tube
placement
children
ome
examin
viral
rna
detect
reversetranscriptas
polymeras
chain
reaction
hrv
result
compar
viru
isol
cell
cultur
vitro
studi
persist
hrv
infect
rna
conduct
combin
median
cell
cultur
infecti
dose
hrv
pool
mee
assay
serial
sampl
week
result
viru
rna
detect
children
hrv
detect
reversetranscriptas
polymeras
chain
reaction
children
ome
viru
isol
children
rsv
rna
found
hcv
children
ome
dual
viral
infect
found
bacteri
pathogen
isol
mee
sampl
associ
viral
rna
case
often
hrv
case
vitro
condit
hrv
cultur
posit
declin
rapidli
day
rna
detect
week
result
suggest
viru
infect
particularli
hrv
infect
either
alon
concurr
bacteria
present
larger
percentag
children
ome
previous
suspect
remain
determin
often
presenc
viral
rna
mee
repres
persist
rna
ongo
viral
replic
recurr
infect
j
pediatr
novirus
respiratori
syncyti
viru
human
coronavirus
although
middl
ear
effus
shown
contain
bacteri
dna
polymeras
chain
reactionbas
amplif
techniqu
antibiot
treatment
infrequ
affect
cours
ome
sever
earlier
studi
indic
virus
may
play
role
pathogenesi
ome
previou
diagnost
tool
detect
hrv
mee
limit
standard
cultur
method
practic
diagnost
method
hcv
infect
studi
examin
mee
children
ome
undergo
tympanostomi
presenc
hrv
reversetranscriptas
pcr
test
viru
cultur
rsv
hcv
rtpcr
studi
potenti
persist
hrv
rna
mee
also
serial
assay
hrv
infect
rna
detect
pool
mee
sampl
hrv
ad
vitro
studi
popul
compris
children
age
month
year
admit
schedul
oper
tympanostomi
andor
adenoidectomi
departp
polymeras
chain
reactionbas
detect
rhinoviru
respiratori
syncyti
viru
coronaviru
otiti
media
effus
ann
md
jussi
jero
md
eurico
arruda
md
anni
virolainen
md
frederick
g
hayden
md
otiti
media
effus
common
childhood
diseas
without
complet
clarifi
etiolog
ome
suggest
continuum
acut
otiti
media
howev
despit
routin
use
antibiot
aom
incid
ome
unit
state
estim
increas
although
epidemiolog
data
support
conclus
weak
young
children
experi
frequent
upper
respiratori
tract
ill
episod
per
year
commonli
associ
virus
human
rhiment
otolaryngolog
helsinki
univers
central
hospit
persist
ome
criteria
diagnosi
ome
includ
presenc
effus
behind
intact
eardrum
determin
pneumat
otoscopi
least
month
subsequ
confirm
tympanostomi
without
sign
symptom
acut
infect
children
bilater
involv
mee
collect
right
ear
children
purul
mee
receiv
antimicrobi
therapi
experienc
upper
respiratori
tract
infect
within
week
studi
includ
durat
ome
base
case
clinic
followup
data
record
patient
physician
patient
enrol
studi
inform
consent
obtain
parent
receiv
gener
anesthesia
procedur
mee
sampl
obtain
tympanostomi
control
oper
microscop
aspir
electr
suction
devic
tymtap
collector
juhn
tymtap
xome
inc
jacksonvil
fla
cottontip
swab
dip
directli
aspir
swab
immedi
place
modifi
stuart
transport
media
transpocult
orion
diagnostica
espoo
finland
transport
microbiolog
laboratori
residu
sampl
rins
polypropylen
microtub
ml
phosphatebuff
salin
store
process
mee
sampl
cultur
bacteria
isol
identifi
standard
method
nineteen
mee
sampl
posit
hrv
determin
rtpcr
inocul
onto
monolay
human
embryon
fibroblast
cell
stain
incub
previous
describ
rtpcr
protocol
primer
sequenc
hrv
hcv
base
publish
method
minor
modif
primer
rsv
direct
f
protein
messeng
rna
follow
nucleotid
posit
revers
transcript
primer
upstream
biotinyl
primer
intern
probe
briefli
rna
extract
use
matrix
affin
chromatographi
qiaamp
blood
kit
qiagen
chatsworth
calif
revers
transcript
carri
volum
virusspecif
oligonucleotid
primer
hrv
rsv
hcv
hcv
revers
transcript
mmlvrt
gibco
brl
gaithersburg
md
reaction
sampl
heat
inactiv
transcriptas
minut
mix
primer
hrv
rsv
hcv
hcv
oc
pcr
buffer
k
invitrogen
san
diego
calif
adjust
final
concentr
primer
mgcl
mmoll
respect
final
ph
tube
held
u
taq
polymeras
appli
biosystem
foster
citi
calif
dilut
water
ad
cycl
pcr
denatur
minut
hrv
minut
hcv
rsv
anneal
minut
hrv
minut
hcv
minut
rsv
dna
synthesi
minut
extens
minut
rhinoviru
type
atcc
rockvil
md
rsv
hcv
provid
kathryn
v
holm
univers
colorado
atcc
use
posit
control
steril
pb
use
neg
control
reaction
seri
unincorpor
primer
deoxyribonuclosid
triphosph
remov
pcr
product
selectb
spin
column
boulder
colo
oligonucleotid
probe
hrv
enteroviru
rsv
hcv
hcv
label
end
digoxigenin
use
nucleotidyltransferas
accord
protocol
manufactur
boehring
mannheim
germani
care
minim
chanc
crosscontamin
contamin
previous
amplifi
dna
includ
physic
segreg
sampl
prepar
pcr
prepar
separ
laminar
flow
hood
execut
pcr
product
analysi
differ
laboratori
well
use
positivedisplac
pipett
dispos
glove
gown
mask
virusspik
mee
dilut
viru
stock
use
posit
control
sampl
test
neg
hrv
hcv
rsv
well
bufferonli
reaction
use
neg
control
amplifi
product
detect
previous
describ
use
microtit
plate
hybrid
pcr
product
sampl
posit
picornaviru
hybrid
subsequ
probe
specif
enteroviru
pcr
product
stock
coxsacki
viru
echoviru
polioviru
prepar
laboratori
use
posit
control
assay
pool
hrv
rnaneg
mee
children
volum
ml
per
experi
equival
volum
pb
inocul
approxim
median
tissu
cultur
infecti
dose
hrv
type
mix
aliquot
remov
combin
pb
dilut
titrat
hela
cell
remaind
frozen
later
assay
rna
rtpcr
describ
inocul
sampl
incub
uninocul
sampl
mee
pb
process
parallel
first
experi
serial
aliquot
remov
day
combin
pb
test
describ
second
experi
use
mee
sampl
aliquot
remov
baselin
week
clinic
demograph
data
avail
mee
sampl
sampl
collect
boy
girl
rang
age
month
year
median
age
month
tabl
effus
either
mucoid
mucopurul
proport
effus
posit
hrv
rsv
hcv
differ
effus
type
tabl
durat
mee
vari
month
median
month
sampl
case
mee
persist
month
longer
bacteri
pathogen
isol
mee
associ
viru
rna
case
hrv
tabl
ii
hrv
posit
tend
associ
frequent
presenc
bacteri
pathogen
compar
rsv
hcv
p
hrv
vs
rsv
fisher
exact
test
among
virusposit
mee
hrv
predomin
year
age
older
wherea
rsv
hrv
almost
equal
promin
children
younger
year
age
hrvposit
sampl
occur
children
histori
effus
tabl
proport
children
prior
tympanostomi
tube
prior
adenoidectomi
frequent
bout
acut
otiti
compar
across
virusposit
group
also
among
virusposit
children
respect
compar
virusneg
children
respect
hrv
detect
throughout
year
except
juli
august
wherea
rsvposit
sampl
occur
novemb
inocul
high
concentr
infecti
hrv
cultur
posit
lost
day
pool
mee
sampl
gradual
decreas
day
pb
tabl
iii
contrast
detect
hrv
rna
rtpcr
persist
day
mee
sampl
lost
day
pb
second
experi
confirm
hrv
rna
detect
last
week
lost
week
vitro
incub
studi
detect
hrv
rsv
hcv
rna
mee
sampl
children
ome
tabl
ii
detect
hrv
rsv
hcv
middl
ear
fluid
children
ome
journal
pediatr
et
al
volum
number
compar
cultur
alon
vs
sampl
correspond
earlier
studi
rtpcr
increas
frequenc
picornaviru
detect
nasal
sampl
compar
cultur
sampl
obtain
adult
patient
asthma
rate
cultur
posit
similar
anoth
studi
hrv
recov
subacut
chronic
case
ome
one
previou
studi
rsv
found
mee
children
ome
rtpcr
frequenc
similar
rate
rsv
detect
anoth
studi
rsv
rna
detect
rtpcr
middl
ear
exud
collect
myringotomi
children
otiti
media
rsv
outbreak
uncertain
often
detect
respiratori
viral
rna
repres
persist
infect
residu
noninfecti
rna
intercurr
infect
children
recent
shown
children
prone
ome
tend
frequent
discret
episod
effus
rather
increas
overal
durat
episod
unfortun
studi
incorpor
simultan
collect
nasopharyng
sampl
examin
presenc
infect
level
respiratori
tract
note
pcrbase
amplif
techniqu
detect
presenc
bacteri
dna
signific
percentag
bacteri
cultureneg
mee
children
middl
ear
caviti
experiment
infect
chinchilla
purifi
bacteri
dna
dna
intact
nonviabl
bacteria
persist
mee
although
antibiotictr
bacteria
persist
viabl
state
week
contrast
known
long
viral
rna
remain
mee
mucosa
without
degrad
separ
studi
found
hrv
rna
detect
rtpcr
day
longer
cultur
nasal
wash
experiment
infect
adult
unpublish
observ
howev
durat
hrv
persist
nasopharynx
may
differ
middl
ear
durat
shed
may
shorter
adult
children
part
differ
immun
compet
order
address
indirectli
question
hrv
persist
mee
collect
hrvneg
mee
ad
larg
amount
infecti
hrv
determin
durabl
infect
rna
detect
assay
although
cultiv
viru
lost
rapidli
mee
rna
detect
persist
day
one
experi
week
anoth
vitro
studi
rais
question
whether
rna
detect
mee
sometim
repres
residu
viral
rna
thick
effus
howev
result
cultureposit
mee
previou
find
hrv
cultureposit
mee
sampl
clearli
indic
activ
hrv
infect
children
whether
repres
chronic
recurr
infect
remain
determin
direct
demonstr
viral
replic
situ
amelior
condit
specif
antivir
therapi
would
provid
evid
product
viral
infect
middl
ear
found
direct
evid
coinfect
viru
particularli
hrv
bacteria
patient
although
mechan
defin
earlier
studi
show
coinfect
rhinoviru
bacteria
indic
failur
resolut
aom
antibiot
treatment
find
support
concept
respiratori
virus
either
alon
combin
bacteria
commonli
associ
ome
viral
infect
caus
obstruct
eustachian
tube
abnorm
middl
ear
pressur
experiment
induc
natur
hrv
infect
may
turn
caus
impair
drainag
middl
ear
repres
one
possibl
mechan
contribut
develop
ome
chang
local
immun
respons
middl
ear
may
anoth
contributori
factor
particularli
secondari
bacteri
infect
occur
although
mechan
clear
crosssect
studi
examin
heterogen
popul
incorpor
sequenti
sampl
time
develop
aom
conclus
pathogenesi
causat
possibl
howev
result
indic
virus
particularli
hrv
either
alon
concurr
bacteria
may
present
greater
percentag
children
ome
previous
suspect
effect
method
prevent
andor
treat
viral
infect
could
signific
impact
import
clinic
problem
thank
owen
hendley
critic
review
manuscript
